Clinical trial
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From…
NCT00026910 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00026910 |
|---|---|
| Title | Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma |
| Official title | Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Non-Hodgkin Lymphoma |
| Enrollment | 200 |
| Start date | Jul 1, 1998 |
| Completion | May 1, 2002 |
| First posted | Nov 15, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: